Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

TPP will not affect the cost of medicines

TPP will not affect the cost of medicines

“Despite claims to the contrary, consumers will not pay more for subsidised medicines as a result of TPP,” says Trade Minister Todd McClay.

“TPP will not change the PHARMAC model.
“PHARMAC will continue to do what it does best, prioritising its spending and negotiating the best price for medicines with suppliers.”

Some administrative changes will be required for PHARMAC to increase transparency under TPP. These include setting a timeframe for considering funding applications (which is up to New Zealand to determine), and to establish a specific review process for funding applications that PHARMAC has declined.
“But TPP has been designed in a way that ensures that PHARMAC can manage these processes,” says Mr McClay.

These are outlined in the Government’s factsheet on pharmaceutical and
medical device purchasing (reimbursement). The administrative changes are expected to involve up to $4.5 million in one-off establishment costs for PHARMAC and up to $2.2 million a year in operating costs.

“These operating costs represent less than 0.3 per cent of New Zealand’s pharmaceutical budget and need to be weighed against the $2.7 billion in GDP gains TPP is estimated to deliver New Zealand in 2030,” says Mr McClay.

A number of earlier, far-reaching proposals relating to medicines and to PHARMAC, proposed by some parties during the TPP negotiations, but rejected by New Zealand and other negotiators, were not included in the final agreement.

The TPP National Interest Analysis (NIA) concludes that TPP would have a very minimal impact on the health system in New Zealand.

Patent provisions will also have minimal effect on New Zealand. There is no change to New Zealand’s standard 20-year patent period. Given the efficiency of New Zealand’s processing times, very few unreasonable delays are expected to occur in New Zealand that would require patent term extension under TPP, and only in exceptional circumstances. While the cost of any delays would depend on the case, the average cost is estimated at NZ$1 million a year.

“These outcomes reflect the Government’s commitment throughout the TPP negotiating process to protect public health and the fundamentals of New Zealand’s health system,” says Mr McClay

The factsheets, PHARMAC costings, and NIA can be found atwww.tpp.mfat.govt.nz. The factsheet is also attached.

ENDS

© Scoop Media

 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

Gordon Campbell: On Why Raising Corporate Taxes Has Become A Hot New Political Cause

Surprisingly, “raising taxes” has become a very fashionable political idea in 2021. That’s right. After decades of being seen (at best) as a necessary evil, higher corporate taxes are now being treated as the Great Good Thing that will revive the US economy, re-distribute wealth productively, help to build neglected and decaying public infrastructure, fund public health, address social inequality, restore a sense of community and generally make everyone feel better about the society in which they live... More>>

 

Government: Delivers Next Phase Of Climate Action

The Government is delivering on a key election commitment to tackle climate change, by banning new low and medium temperature coal-fired boilers and partnering with the private sector to help it transition away from fossil fuels. This is the first ... More>>

Government: Independent Experts To Advise On Post-Vaccination Future

The Government is acting to ensure decisions on responding to the next phase of the COVID-19 pandemic are informed by the best available scientific evidence and strategic public health advice. “New Zealand has worked towards an elimination ... More>>

Travel: Trans-Tasman Bubble To Start 19 April

New Zealand’s successful management of COVID means quarantine-free travel between New Zealand and Australia will start on Monday 19 April, Prime Minister Jacinda Ardern announced today. Prime Minister Jacinda Ardern and COVID-19 Response Minister Chris ... More>>

ALSO:


Health: Drug-Testing Law To Be Made Permanent

Interim legislation that is already proving to keep people safer from drugs will be made permanent, Health Minister Andrew Little says. More>>

World Travel: New Zealand Temporarily Suspending Travel From India - PM Jacinda Ardern

Travel into New Zealand from India - including for New Zealand citizens and residents - is being temporarily suspended because of high numbers of Covid-19 cases. More>>

Finance: Crown Accounts Again Better Than Forecast

Hon Grant Robertson Minister of Finance The economic recovery from COVID-19 continues to be reflected in the Government’s books, which are again better than expected. The Crown accounts for the eight months to the end of February 2021 showed both OBEGAL ... More>>

 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels